| Financial Year |
March 31 2023 |
| Monetary Funds |
737,528,454.83 |
| Held-for-trading Financial Assets |
49,000,000.00 |
| Notes Receivable |
277,207,413.70 |
| Accounts Receivable |
517,306,098.70 |
| Advances to Suppliers |
60,415,532.08 |
| Other Receivables |
21,967,100.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
593,308,054.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
58,239,704.66 |
| Total Current Assets |
2,347,306,839.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,594,587.01 |
| Investment Properties |
54,999,446.51 |
| Fixed Assetes |
1,104,360,629.52 |
| Under-construction Projects |
122,626,408.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
632,317,814.19 |
| R&D expenses |
39,627,413.34 |
| Goodwill |
809,858,773.65 |
| Long-Term Deferred and Prepaid Expenses |
39,745,251.88 |
| Deferred Income Tax Assets |
40,519,277.52 |
| Other Non-Current Assets |
473,287.29 |
| Sub-Total of Non-Current Assets |
2,984,358,761.83 |
| Total Assets |
5,331,665,600.85 |
| Short-Term Loans |
389,140,197.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
135,098,717.40 |
| Accounts Payable |
263,353,094.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,137,878.00 |
| Taxes Payable |
10,011,748.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,804,685.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
82,608,427.72 |
| Other Current Liabilities |
40,468,325.41 |
| Sub-Total of Current Liabilities |
1,028,567,017.93 |
| Long-term Loans |
186,668,416.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
189,204,171.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,423,614.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
457,148,955.58 |
| Total Liabilities |
1,485,715,973.51 |
| Paid-In Capital(Or Share Stock) |
679,156,000.00 |
| Capital Surplus |
860,506,337.75 |
| Surplus Reserve |
219,643,552.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,863,712,402.42 |
| Minority Stockholder's Interest |
222,715,041.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,623,234,585.41 |
| Owner's Equity（Stockholder's Equity） |
3,845,949,627.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,331,665,600.85 |
